For years, financial challenges have shadowed the world’s public and private health systems to varying degrees, and experts expect the situation to persist in 2020. The entry of non-traditional players in the health care sector have the potential to both support and suppress incumbent efforts to grow revenue.
- Healthcare stakeholders are implementing payment reforms such as value-based payment models that help providers, payers, and patients achieve the best outcomes at the lowest cost
- Technology-enabled patient engagement strategies are enabling increased financial independence for patients in their healthcare decisions, in addition to improving interactions with their healthcare systems
- Governments are also moving the needle by adopting universal health coverage and introducing pricing controls on pharmaceuticals and medical technology devices
- Population health management (PHM) is being used to identify people’s health care needs and offer services accordingly.
Health care stakeholders further need to invest in value-based care, innovative care delivery models, advanced digital technologies, data interoperability, and alternative employment models to prepare for these uncertainties and build a smart health ecosystem.
Major healthcare segments
- AI-Companies selling AI SaaS to healthcare clients or using AI to develop products for the healthcare market.
- TELEHEALTH-Startups using technology to remotely deliver clinical health services to patients
- MEDICAL DEVICES-Companies developing medical devices that aid in the diagnosis, cure, mitigation, treatment, monitoring, or prevention of disease.
- DIGITAL HEALTH IN CHINA-China-based healthcare startups using digital technology as a key differentiator over their competition.
- WOMEN’S HEALTH-Startups focused specifically on providing healthcare products and services to women.
- MENTAL HEALTH-Companies applying technology to problems of emotional, psychological, and social well-being.
Global stock markets plunged in March due to the COIVD-19 outbreak which wiped the market cap of the major companies on a grander scale. Many industries fell victim to the pandemic crisis.
However, the healthcare industry gained momentum after the dip in March 2020, Most of the healthcare companies saw their stock moving upwards due to rise in demand for medial goods and medicines.
Here, in this report, we discuss the performance of the Healthcare companies and how they have been impacted by C-19 pandemic:
For details on each of the above company, industry outlook and segment performance please feel free to refer to other reports from Crispidea.